Global Translational Regenerative Medicine Market Prospects 2017-2027
NEW YORK, June 1, 2017 /PRNewswire/ -- Report Details
The translational regenerative medicine market has been undergoing considerable changes over the last few years. There are a number of therapies that have been launched into the market over the last few years. Stem cell therapies are being developed constantly and these are targeted at various indications, from the more common cardiovascular conditions to rarer orphan indications.
Read the full report: http://www.reportlinker.com/p04928836/Global-Translational-Regenerative-Medicine-Market-Prospects.html
The Global Translational Regenerative Medicine market is expected to grow significantly over the forecast period. The Global Translational Regenerative Medicine market was valued at $5.8bn in 2016. Visiongain forecasts this market to increase to $14.5bn in 2021. The market is estimated to grow at a CAGR of 19.9% in the first half of the forecast period and 17.7% from 2016 to 2027.
How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new report you find 316-page report you will receive 107 tables and 66 figures – all unavailable elsewhere.
The 316-page report provides clear detailed insight into the Global Translational Regenerative Medicine market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand new report today you stay better informed and ready to act.
Report Scope
• Global Translational Regenerative Medicine market forecasts from 2017-2027
• Translational Regenerative Medicine regional market forecasts from 2017-2027, covering:
- United States
- Europe
- Asia-Pacific
- Rest of the World
• Global Translational Regenerative Medicine submarket forecasts from 2017-2027 covering:
- Stem Cell Therapies
- Tissue Engineered Products
- Gene Therapies
• Forecasts from 2017-2027 of the leading products in the Global Translational Regenerative Medicine market:
- Osteocel Plus
- Trinity ELITE
- TEMCELL /Prochymal
- Apligraf
- Dermagraft
- Epifix
- ReCell
- Neovasculgen
- Glybera (alipogene tiparvovec)
- IMLYGIC (talimogene laherparepvec)
• Assessment of the leading companies in the Global Translational Regenerative Medicine market:
- Alphatec Spine
- Anterogen
- Athersys
- Avita Medical
- AxoGen
- Medipost
- Mesoblast
- NuVasive
- Ocata Therapeutics
- Organogenesis
- Osiris Therapeutics
- Pharmicell
- Regenerys
- TiGenix
- UniQure
- Vericel Corporation
Read the full report: http://www.reportlinker.com/p04928836/Global-Translational-Regenerative-Medicine-Market-Prospects.html
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
http://www.reportlinker.com
__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001
SOURCE Reportlinker
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article